Ghrelin, an endogenous ligand for growth hormone secretagogue receptor (GHS-R), is known to increase food intake in lean humans and rodents. In addition, ghrelin levels are increased by fasting in lean rodents and are elevated before meals in humans, suggesting an important role for ghrelin in meal initiation. However, in obese human, circulating ghrelin levels were found to be significantly reduced as compared to lean individuals. OBJECTIVES: To evaluate whether circulating ghrelin levels, as well as ghrelin sensitivity, are decreased in obese individuals in order to limit its effect on food intake. DESIGN: Lean C57BL/6J mice fed a chow, a low-(LFD) or a high-fat diet (HFD) were used to determine ghrelin regulation and secretion as well as ghrelin sensitivity. MEASUREMENTS: Plasma ghrelin levels were measured in low-and high-fat fed mice. Ghrelin-induced food intake was measured in chow, low-and high-fat fed mice. RESULTS: We measured ghrelin levels in lean and diet-induced obese mice, fed on an LFD or an HFD, respectively. We observed that not only ghrelin secretion was reduced in obese mice but its diurnal regulation was also lost. In addition, we failed to observe any change in ghrelin secretion upon fasting and refeeding. Moreover, we observed that the sensitivity to the orexigenic effects of exogenous ghrelin was reduced in obese mice when compared to lean mice fed a chow or a LFD. The insensitivity of obese mice to ghrelin was improved upon weigh loss. CONCLUSION: Altogether, these results indicate that ghrelin secretion and regulation is impaired in dietary-induced obesity in mice and suggest that ghrelin inhibition could prevent weight regain after weight loss.
Introduction
Ghrelin is a 28 amino-acid orexigenic peptide released in large amounts by the stomach and to a lesser extent by the pancreas, kidneys, liver, pituitary and hypothalamus. 1, 2 To be active, ghrelin needs to be modified by addition of an noctanoyl group on the serine 3 residue. 2 This post-translational modification is essential for ghrelin to produce its biological effects through the growth hormone secretagogue receptor (GHS-R), 3 which is mainly expressed in the pituitary, hypothalamus, vagal nodose ganglia, heart, pancreas and liver. 1, 4 Downstream effects of ghrelin seem to be mediated through central pathways, since exogenous administration of ghrelin, either centrally or peripherally, leads to the activation of orexigenic peptides, such as neuropeptide Y. [5] [6] [7] In addition to its major role in regulation of food intake, ghrelin has also been reported to regulate gastric emptying 8 and gastric acid secretion 9 as well as secretion of growth hormone. 4, 10, 11 In lean rodents, ghrelin levels have been reported to be increased by fasting. 12, 13 Similarly, circulating ghrelin levels were found to be elevated before meals in humans, suggesting an important role for ghrelin in meal initiation. 14, 15 Chronic administration of ghrelin in rodents led to significant increase in body weight 5, 12, 16 as well as hyperphagia. 5, 11, 16 This increased body weight was mostly explained by the accumulation of fat and elevated respiratory quotient. 12, 16 Interestingly, in obese humans and rodents, circulating ghrelin levels are significantly reduced as compared to lean individuals. [17] [18] [19] Importantly, those levels inversely correlate with BMI and fasting insulin levels 20 and are restored upon weight loss. 21 These results may indicate that circulating ghrelin levels are decreased in obese individuals in order to limit its effect on food intake. To date, there are no available data on the orexigenic effects of ghrelin administration in obese when compared to lean individuals. To test this hypothesis, we examined the effect of diet-induced obesity on circulating ghrelin levels. In addition, we investigated if obesity and dietary fat may affect the ability of ghrelin to increase food intake.
Methods

Animals
Lean C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA 
Body composition
Body composition was measured using dual X-ray absorptiometry (DEXA) with a Lunar Piximus (GE).
Ghrelin synthesis and measurement
The bioactive form of ghrelin (O-n-octanoyl-[Ser 3 ]) was synthesized by BioPeptide Co. (San Diego, CA, USA). Endogenous ghrelin was measured in plasma using a commercial radioimmunoassay (Phoenix Pharmaceuticals, CA, USA). The lower limit of detection was 0.1 ng/ml and the intra-assay variability was 1%.
Statistics
Statistical analyses were carried out using analysis of variance and post hoc group comparisons (Tukey). Probability values less than 5% were considered significant.
Results
Effects of HFD feeding in mice
The effects of high-fat feeding on body weight and body fat in mice is indicated in Figure 1 . After 20 weeks, mice fed a LFD gained approximately 17 g whereas mice fed a HFD gained 31 g of body weight. Body composition studies using Ghrelin regulation in obese mice M Perreault et al DEXA indicated that the extra weight gain in HFD fed mice was mostly due to accumulation of body fat.
Ghrelin secretion in dietary obese mice
Ghrelin secretion during the light/dark cycle. As shown in Figure 2a , we observed a diurnal secretion of ghrelin with two major peaks (Po0.001) occurring in free fed lean mice. The first peak occurred 2 h before light onset and the amplitude of the peak was 1.50 ng/ml. The second peak occurred during the transition from light to dark and its amplitude was more pronounced than the first one (1.82 ng/ ml). A third peak was also observed between 0800 and 2400 but no significant difference was observed. In DIO mice, the first peak persisted with lower amplitude (0.79 ng/ml). However, the second peak almost disappeared. Interestingly, overall ghrelin levels during the light and the dark phases were lower in DIO mice when compared to lean animals (light phase: 1.2370.24 ng/ml in lean and 0.8670.18 ng/ml in DIO. Dark phase: 0.9570.3 ng/ml in lean and 0.6370.15 ng/ml in DIO).
Ghrelin secretion during fasting and refeeding. The effect of fasting and refeeding on circulating ghrelin in both lean and DIO mice is shown in Figure 2b . In this experiment, we observed basal ghrelin levels to be similar between lean and DIO mice. However, 16 h fasting significantly increased ghrelin levels by 2.1-fold in lean animals. Immediately after refeeding (within 1 h), ghrelin levels returned to the initial value. Surprisingly, the same fasting conditions had no significant effect on ghrelin secretion in the DIO mice but refeeding decreased ghrelin levels in those animals with a slower onset (significant effect observed only 12 h after refeeding).
Ghrelin challenge in lean and DIO mice. When injected in 8-week old lean C57BL/6 mice fed a regular chow diet, ghrelin (i.p.) induced a dose-dependent and long-lasting increase in food intake ( Figure 3a) . We found that the minimal dose of ghrelin having an effect at 2 h was 100 nmol/mouse. When injected in 20 weeks old lean C57BL/6 fed on a LFD, ghrelin (i.p.) also induced a dosedependent increase in food intake (Figure 3b ). In these animals, the minimal dose of ghrelin having an effect at 2 h was similar. However, in age-matched DIO mice fed on HFD, ghrelin had no effect on food intake. EC 50 s (half effective dose) and E max (maximal effect) were the following: the EC 50 s for chow lean LFD were 166 and 32 nmol, respectively. The E max were 4.5 and 2.4 kcal, respectively. No effects on food intake were observed in the DIO mice. Ghrelin regulation in obese mice M Perreault et al
Ghrelin challenge in DIO mice switched to LFD. As expected, the DIO mice switched to LFD lost weight when compared to the ones maintained on HFD ( Figure 4a ). As indicated in Figure 4b , we observed that 3 days of LFD feeding restored ghrelin sensitivity in the DIO mice, as demonstrated by the feeding response of LFD mice to 300 nmol/mouse of ghrelin. This effect was even more pronounced after 14 days on LFD (Figure 4b ; 376 vs 185%).
Discussion
Effects of dietary-induced obesity on circulating ghrelin in mice In order to determine the diurnal regulation of circulating ghrelin in both lean and DIO mice, we measured ghrelin levels in free fed animals during 24 h. As expected, exposure of lean animals to HFD for 16 weeks induced obesity. 23, 24 It has been reported previously that similar diet (60% kcal from fat) increased significantly body weight, adipose tissue mass as well as plasma leptin levels, without affecting muscle mass. 23 We observed a diurnal variation in the secretion of ghrelin in free fed lean mice with two major peaks occurring during the transition of phases. The first peak occurred between 1600 and 2000 hours, at a time during which mice normally have a large food intake. 25 The second peak occurred at the end of the dark period and was proposed to be responsible for gastric acid secretion. 13 This pattern is very similar to the diurnal rhythm of ghrelin secretion observed in lean humans and animals. 13, 15 Murakami et al have reported that ghrelin is secreted with two major peaks occurring at 1500 during the light phase and 0600 during the dark phase. Although the first peak appeared earlier in their study, the general secretion pattern was about the same, where ghrelin peaks at the end of both the light and dark periods. In the contrary, the light-to-dark transition induced peak almost disappeared in DIO mice. Interestingly, ghrelin levels during the light and the dark phases were lower in DIO mice when compared to lean animals (Po0.05), as previously described in obese humans and rats. 13, 19, 26 These results would indicate that not only ghrelin secretion is Ghrelin regulation in obese mice M Perreault et al reduced in obese mice but that its diurnal regulation is lost. It could also indicate that meal initiation is not preceded by a rise in ghrelin in DIO mice. To test this hypothesis, we investigated the regulation of circulating ghrelin by feeding states in both lean and DIO mice. We observed that basal ghrelin levels were similar between lean and DIO mice before feeding (1800 in Figure 2b ). This similarity may be explained by the time at which the bleedings were performed. The basal value (before fasting) was measured at 1800 and comparable ghrelin levels between lean and DIO ad-lib fed mice were also observed at 1800 in the diurnal regulation of circulating ghrelin (Figure 2a) . As recently published, 12, 13 we found that fasting significantly increased ghrelin levels in lean mice. However, in DIO mice, we failed to observe any significant change in ghrelin secretion upon fasting. This disregulation of ghrelin secretion by fasting in obesity was also reported previously in Zucker rats. 17 Ariyasu et al reported that ghrelin secretion was delayed upon fasting in Zucker fa/fa rats as compared to control rats. In fact, 24 h fasting significantly increased ghrelin levels only in lean rats whereas at least 48 h fasting was required to increase ghrelin in obese fa/fa rats. This could indicate that ghrelin levels in DIO mice would be increased upon longer fasting. The delay in ghrelin secretion upon fasting in obese animals may be partly explained by an excess of energy deposit.
Effects of dietary-induced obesity on ghrelin sensitivity in mice
It is known that exogenous ghrelin, when administered centrally or peripherally, has an orexigenic effect in rats and mice. 5, 8, 11 We speculated that the decrease in circulating ghrelin observed in the DIO mice could be a regulatory phenomenon in order to limit its effect on food intake. To test this hypothesis, we injected ghrelin peripherally in lean and DIO animals, fed a LFD and a HFD, respectively. When injected in chow fed lean C57BL/6 mice (9-week old), ghrelin induced a dose-dependent increase in food intake, with a minimal effective dose of 100 nmol/mouse. The effect on food intake lasted for at least 8 h. When the same experiment was conducted in LFD mice (20-week old), ghrelin produced also a dose-dependent effect on food intake, with a similar minimal effective dose, albeit with a lower magnitude of the feeding response. However, when injected in age-matched DIO mice (20-week old), we found that ghrelin did not increase food intake at doses up to 600 nmol/mouse, indicating that the DIO animals had lost their sensitivity to exogenously administered ghrelin. The efficacious doses of ghrelin used for our studies were much higher than those reported to be effective in the literature. It was shown that ghrelin as low as 10 mg significantly increased cumulative food intake in mice, 8, 27 producing an increase in food intake as small as 50 mg. In our case, higher doses of ghrelin had to be used to induce a reliable and measurable effect. Another factor that can explain the differences observed between our study and those reported in the literature is the strain of mice used in the experiment. We have conducted our experiment in C57BL/6J mice, whereas they performed their studies using ddy mice.
Dietary modulation of ghrelin sensitivity in obese mice
In order to determine whether obesity may be responsible for the observed decrease in ghrelin sensitivity in DIO mice, we measured the effect of peripherally injected ghrelin on food intake in DIO mice and DIO mice switched to a LFD for a short (3 days) and an extended period of time (13 days). As expected, when switched to LFD, the animals readjusted their body weight. Our results indicate that 3 days of LFD feeding were enough to restore the positive effect of peripherally injected ghrelin on food intake. This effect was even more pronounced after 13 days on LFD, when body weight was at a level comparable to lean mice fed on a LFD. These results indicate that dietary-induced obesity in mice is accompanied by a state of resistance to the peripheral effect of ghrelin on feeding and that weight loss can restore the sensitivity to ghrelin. Moreover, the rapid reversal of ghrelin insensitivity in DIO mice suggests that not only obesity but also dietary fat content might be responsible for the decrease in ghrelin sensitivity observed in the obese animals.
In this paper, we focused on the effects of ghrelin when injected peripherally. We hypothesized that peripheral effects of ghrelin are important since ghrelin is synthesized in the stomach and released in the circulation and also because circulating ghrelin levels are regulated under conditions of negative (fasting, anorexia) or positive (obesity, feeding) energy balance. 6, 12, 18 It has been demonstrated that C57BL/6J mice develop a resistance to peripheral administrated leptin when fed an HFD, 23, 28 concomitantly to an increase in food intake when compared to LFD fed mice. 23 Interestingly, in dietary obese rodents, circulating ghrelin levels are negatively correlated to those of leptin 19 and both hormones levels are sensitive to the fat content of the diet. 19, 29 Moreover, leptin administration in mice has been demonstrated to induce a decrease in ghrelin expression. 8 There is evidence that ghrelin signals are integrated in the hypothalamus, 30, 31 at the level of leptin-sensitive neurons, 31 and more probably via neuropeptide Y/AGRP and/or orexin pathway. [32] [33] [34] These two pathways are modulated by obesity in mice 35, 36 and their orexigenic effect are modulated by leptin. 35, 37 Moreover, the effects of ghrelin on food intake are blocked by neuropeptide Y Y1 and Y5 antagonists 38, 39 and are partially blunted in the orexin knockout mice. 33 Altogether, these results may suggest that NPY and orexin pathways could be implicated in the reduced sensitivity of dietary obese mice to orexigenic effects of ghrelin. One possible explanation for the reduced ghrelin sensitivity observed in DIO mice could be that the increased leptin levels lead to the negative regulation of the NPY/AGRP pathway. Leptin blocks NPY/AGRP in order to reduce food intake but, by the same way, prevents ghrelin's orexigenic
Ghrelin regulation in obese mice M Perreault et al effects. However, after weight loss, leptin levels are reduced and NPY/AGRP pathway is no longer inhibited, thus ghrelin sensitivity is restored. On the other hand, it has been proposed that circulating ghrelin is acting through ghrelin receptors located in nodose gangliosa of the vagal nerve. 4 Moreover, recent data showed that peripheral, but not central, administration of ghrelin loses its orexigenic effect in vagotomized animals. 4, 8 These results suggest that ghrelin may act through two different mechanisms to stimulate food intake: one central and one peripheral. Whether the reduced sensitivity to the effect of ghrelin in DIO mice is mediated by one or the other (or both) is not known. Further experiments are underway to investigate the respective role of these two sites in ghrelin insensitivity in the DIO mice.
In conclusion, our results indicate that HFD-induced obesity in mice is associated with a decrease in the circulating levels of ghrelin and a loss of regulation by the nycthemeral cycle and the feeding status. We also demonstrate here for the first time that these effects are associated with an unexpected decrease in ghrelin sensitivity in obese animals. Furthermore, our results indicate that the sensitivity to ghrelin can be restored during weigh loss, suggesting that dietary fat content could modulate ghrelin sensitivity in rodents.
